lims healthcare selection: what a healthcare lims must do that a research system need not, and the interfaces that decide the project
A laboratory system in a healthcare setting carries obligations a research system does not: it holds identifiable patient data, it exchanges orders and results with clinical systems, and it operates inside an accreditation regime that will inspect it. Those three things, rather than the feature list, are what separate the products in this market. This page covers what to establish before a selection.
- the US programme a laboratory must operate under to report a clinical result
- CLIA
- the FDA rule on electronic records and signatures
- Part 11
- the ISO/IEC standard testing and calibration labs are accredited against
- 17025
Figures in this panel are the regimes a clinical or healthcare laboratory system is bought against, named from the programmes themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a systems price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
What separates a clinical system
- Patient identity and the master index. The system must resolve a patient reliably across orders, episodes and identifiers, and merge duplicates safely. This is harder than it sounds and it is where clinical systems differ most from research ones, which key everything to a sample.
- Order and result interfaces. Orders arrive from and results return to electronic health records, and those interfaces are the project. Establish which standards the system supports, which are in production at a named comparable customer, and who builds and maintains each interface.
- Accreditation and the inspection. The laboratory operates under an accreditation regime that inspects records, competency, quality control and corrective actions. Ask specifically how the system supports the evidence an inspector asks for rather than whether it is compliant, which is a claim rather than a capability.
- Quality control and proficiency testing. Control rules, control charts, out-of-control handling and proficiency testing records are daily operational work in a clinical laboratory. A system that treats them as reports rather than as workflow will be worked around.
- Turnaround and the critical result. The system must support turnaround monitoring and the escalation of a critical result to a named person with acknowledgement recorded. Confirm how that path works and what happens when acknowledgement does not arrive.
Research systems do not become clinical systems
A research laboratory information system can be excellent and still lack patient identity management, clinical interfaces and the accreditation evidence trail. Extending one into clinical use is a much larger undertaking than buying a product built for it, and the gap appears at the worst time.
Where an organisation genuinely does both, running two systems with a defined boundary is usually more honest than stretching one across both regimes.
Data protection sits on top of everything
Identifiable health data carries access control, audit, retention and breach obligations that apply to the system, its backups and any hosting arrangement. Establish where data sits, who can reach it and what the provider's obligations are before selection rather than during contracting.
Ask how the system supports a subject access request and a correction, because those are routine operational events and awkward to satisfy retrospectively.
Common questions
- How does a healthcare LIMS differ from a research one?
- It manages patient identity across episodes, exchanges orders and results with clinical systems, and produces the evidence an accreditation inspection asks for. Research systems key everything to a sample and lack all three.
- Can a research LIMS be extended for clinical use?
- Rarely well. Patient identity management, clinical interfaces and the accreditation evidence trail are substantial gaps, and extending across them usually costs more than buying a product built for the regime.
- What decides the project timeline?
- The interfaces with clinical systems. Establish which standards are supported, which are live at a named comparable customer, and who builds and maintains each one.
- What should I ask about accreditation support?
- Not whether the system is compliant, which is a claim, but how it produces the specific evidence an inspector asks for: records, competency, quality control and corrective actions.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/lims-healthcare/.